Magtein® - official distributor for the CEE region

CzechEnglish
ATA Mg® – magnesium acetyl taurinate, an EU-authorised source of magnesium
Ingredient

ATA Mg® – magnesium acetyl taurinate, an EU-authorised source of magnesium

ATA Mg® – magnesium acetyl taurinate

ATA Mg® is an EU-authorised source of magnesium that also supplies N-acetyltaurine – a differentiated, branded raw material manufactured in the EU, ready for use in your formulations. At Nutraseu we offer it as a second authorised magnesium raw material alongside Magtein®.

What is ATA Mg®

ATA Mg® is magnesium acetyl taurinate (CAS 75350-40-2) – a magnesium salt in which magnesium is bound to acetylated taurine (N-acetyltaurine). The material contains approximately 93% N-acetyltaurine and 6.5–6.9% magnesium. It is a white, largely odourless powder manufactured in the EU (Synapharm, Belgium). With every batch we provide a certificate of analysis (COA) and a specification documenting the identity, content and purity of the material (including magnesium and acetyltaurine content, residual solvents and heavy metals).

Regulatory status in the EU

Magnesium acetyl taurate is an authorised source of magnesium for food supplements in the European Union – it is listed in Annex II of Directive 2002/46/EC. It was added to the permitted sources of magnesium by Commission Regulation (EC) No 1170/2009, based on the 2009 safety opinion of the European Food Safety Authority (EFSA). As a source of magnesium in food supplements it is therefore legally usable in the EU, and has been for longer than most newer forms. EFSA assessed the safety of the material as acceptable within the proposed levels of use.

What can be stated under EU rules

For magnesium as a nutrient, general health claims are authorised in the EU (Regulation (EU) 432/2012) – for example, that magnesium contributes to normal functioning of the nervous system, to normal psychological function, to the reduction of tiredness and fatigue, or to normal muscle function. These claims relate to magnesium in general and may be used when 15% of the reference intake of magnesium is reached (375 mg, i.e. 56.25 mg of magnesium per daily dose). There is no specific authorised health claim for acetyl taurate or for taurine as such – we therefore position ATA Mg® as a source of magnesium, not as a product with claims beyond magnesium.

Properties and formulation options

ATA Mg® is a soluble powder suitable for common food supplement formats – capsules, tablets, sachets and gummies. In addition to magnesium, it also supplies N-acetyltaurine, an acetylated form of taurine, which makes it a compositionally different raw material from common magnesium salts. Given the relatively low proportion of elemental magnesium, formulation needs to account for a correspondingly higher amount of the raw material to achieve the required magnesium content, or to meet the 15% reference intake needed to use general magnesium claims. The material is manufactured in the EU, which simplifies traceability of origin and documentation.

What the research says

Please note: the following summary describes published studies; it is not an authorised health claim and we do not use it as a claim about the product's effects.

The available data on acetyl taurate are predominantly preclinical. In rats, absorption and entry of magnesium into tissues have been described (Uysal 2018; Ates 2019). In rats on a low-magnesium diet and in a mouse model, changes in electrophysiological markers of synaptic plasticity in the hippocampus have been described (Fassin 2020); that study used a small number of animals and one of the co-authors is affiliated with the manufacturer. Robust human data are still lacking – there is no reliable human randomised study on which claims about specific effects could be based. We therefore present the material on the basis of its regulatory status and composition, not on the basis of unconfirmed physiological effects.

Why add ATA Mg® to your portfolio

ATA Mg® gives manufacturers several concrete advantages – legal use in the EU, product differentiation, and simple EU-based supply. In short:

  • Legal across the EU, with no risk. Magnesium acetyl taurate is listed in Annex II of Directive 2002/46/EC as a permitted source of magnesium – you can use it in manufacturing food supplements for the EU market with the certainty of a clear regulatory status, without having to deal with novel food authorisation.
  • A differentiated product. In addition to magnesium, it supplies N-acetyltaurine – it is compositionally different from common magnesium salts and lets you offer something more than standard magnesium.
  • A branded ingredient for your label. ATA Mg® is a trademark-protected raw material that you can list on the final product as a recognisable ingredient.
  • An in-demand category. Magnesium has long been one of the most common food supplement categories, and taurine is a widely used ingredient – ATA Mg® combines them into a single raw material.
  • Flexible formulation. A soluble powder suitable for capsules, tablets, sachets and gummies.
  • EU origin. A raw material manufactured in the EU means a shorter, traceable supply chain and easier documentation, without the complications of importing from third countries.
  • Full documentation with every batch. COA and specification – less work for your quality control.
  • Two authorised magnesium raw materials from one supplier. You can source both ATA Mg® and Magtein® from one place, with unified documentation and Nutraseu's regulatory support.

PRODUCT FAQ

Write to us at info@nutraseu.eu or call +420 734 400 730. We'll be happy to send documentation and a quote.

Sources:
Annex II to Directive 2002/46/EC (consolidated text); Regulation (EC) No 1170/2009; Regulation (EU) 432/2012. EFSA Panel ANS, EFSA Journal 2009;947. Uysal N, et al. Biol Trace Elem Res. 2018;187(1):128–136 (rats). Ates M, et al. Biol Trace Elem Res. 2019;192(2):244–251 (rats). Fassin M, Danhier P, Ris L. Magnes Res. 2020;33(4):106–113 (rodents).

Contact

Magtein® distributor for the Central and Eastern European region:

Nutraseu s.r.o.
Litoměřická 834/19D, 190 00 Praha 9
IČ: 19115415
VAT ID: CZ19115415

Partner With Us